Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial-Reference-Cited by-同舟云学术

Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

Published:2013-07-09 Issue:1 Volume:11 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Zhao Yong,Jiang Zhaoshun,Zhao Tingbao,Ye Mingliang,Hu Chengjin,Zhou Huimin,Yin Zhaohui,Chen Yana,Zhang Ye,Wang Shanfeng,Shen Jie,Thaker Hatim,Jain Summit,Li Yunxiang,Diao Yalin,Chen Yingjian,Sun Xiaoming,Fisk Mary Beth,Li Heng

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1741-7015-11-160.pdf

Reference67 articles.

1. Diamond J: Medicine: diabetes in India. Nature. 2011, 469: 478-479. 10.1038/469478a.

2. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.

3. Zhao Y, Jiang Z, Guo C: New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells. Autoimmun Rev. 2011, 11: 137-142. 10.1016/j.autrev.2011.09.003.

4. Loke YK, Kwok CS, Singh S: Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ. 2011, 342: d1309-10.1136/bmj.d1309.

5. Stephenson J: Diabetes drug may be associated with increase in risk of bladder cancer. JAMA. 2011, 306: 143-10.1001/jama.2011.939.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increase in the Expression of Glucose Transporter 2 (GLUT2) on the Peripheral Blood Insulin-Producing Cells (PB-IPC) in Type 1 Diabetic Patients after Receiving Stem Cell Educator Therapy;International Journal of Molecular Sciences;2024-07-30

2. The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy;Frontiers in Immunology;2024-04-24

3. Cord Blood-Derived Multipotent Stem Cells Ameliorate in Vitro/in Vivo Alloreactive Responses, and This Effect Is Associated with Exosomal Microvesicles in Vitro;Transplantation and Cellular Therapy;2024-04

4. Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes;Scientific Reports;2024-03-25

5. Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism;International Journal of Molecular Sciences;2024-02-02